Tasnee Ethylene Expansion in Trial Phase, Q3 2026 Earnings Impact

Tasnee's Q3 2026 timeline for the earnings impact accounts for the trial period and the ramp-up to stable commercial rates. Any delays in resolving equipment issues during trial production would push that timeline deeper into the year. The company has not disclosed a specific trial duration. Crackers run continuously once operational, so problems discovered during trial that require a shutdown and repair can add weeks.

The expansion adds ethylene capacity into a market where Middle Eastern producers are already bringing new supply. Domestic downstream polyethylene production will absorb some of the incremental output. Exported volumes will compete with product from other regional and global producers. Margins for petrochemical producers depend on where regional supply and global demand settle at the time of commercial launch. Feedstock costs add another layer.

For Tasnee shares, the two variables to track are the trial phase completion and the ethylene-polyethylene price spread at the commercial launch date. The recent maintenance shutdown had little stock impact. The expansion carries more weight because of the capacity increase and its direct contribution to revenue.

Tasnee will file periodic updates with Tadawul through the trial phase, the filing said. Each disclosure will test whether the Q3 2026 commercial timeline holds.